Bitget Institutional has launched Project Archimedes, a $300 million institutional capital program aimed at quantitative trading firms, asset managers, and market makers. The initiative is designed to expand funding access for market-neutral strategies and reduce funding costs for eligible institutions through a combination of capital provision and interest-free lending.
The program rolls out in two tracks: a $100 million Capital Provider Program targeting emerging and growing quantitative firms, and a $200 million interest-free lending program for established institutions with mature strategies and existing trading scale. Bitget said the program will support firms across different growth stages while tying capital deployment to agreed return structures and risk frameworks.
Key takeaways
- Price move: Not applicable—this is a program launch rather than a market trade.
- Catalyst: Bitget Institutional’s launch of Project Archimedes, backed by $300 million in institutional funding.
- Program structure: $100 million capital provision for emerging quant firms and $200 million interest-free lending for established institutions.
- Key implication: The program targets a capital constraint in quantitative execution, focusing on market-neutral approaches and tighter capital-and-risk alignment.
What Project Archimedes is offering
According to Bitget, Project Archimedes is structured to provide two types of support. The Capital Provider Program allocates $100 million to accelerate emerging and growing quantitative firms running market-neutral strategies. Under this track, Bitget provides capital, with returns shared under an agreed structure and within a defined risk framework.
The second track, the interest-free lending program, provides $200 million to established institutions with mature strategies and existing trading scale. Bitget said eligible firms can access interest-free capital by meeting defined trading volume or position requirements, which is intended to lower financing costs while increasing the capital available to their strategies.
Why capital access is becoming a focus for quant firms
Bitget said institutional trading is entering a period where the ability to scale increasingly depends on access to capital, execution quality, and risk control. In particular, the company pointed to tightening arbitrage returns across established crypto markets as competition increases—pushing quantitative firms to refine strategies that rely on market structure rather than broader yield.
Bitget referenced strategy areas that include basis spreads, funding-rate differences, and tokenized assets. These approaches often require firms to hold positions on both sides of a trade, which can lock up margin across separate accounts and constrain how much capital can be deployed.
How Bitget plans to improve capital efficiency
One example Bitget highlighted involves tokenized US stocks. The company said arbitrage opportunities can emerge from differences in basis and funding rates between spot and derivatives markets. It added that such strategies typically require maintaining positions on both sides of the trade, which can tie up margin across separate accounts—an issue for institutions seeking to scale efficiently.
Bitget said its Unified Account architecture can address this by allowing eligible rToken spot positions to serve as collateral for derivatives trading without requiring transfers between accounts. Under this design, institutions can maintain tokenized stock exposure while deploying related contract strategies within the same account, improving how available capital is utilized.
The company also said weekend collateral valuation follows the underlying stock’s Friday closing price, providing a fixed reference point when traditional US markets are closed.
Eligibility, governance, and disclosure
Project Archimedes, according to Bitget, will initially focus on market-neutral strategies with established operating histories and measurable risk controls. Participating institutions will undergo strategy assessment, due diligence, and drawdown reviews, with participation subject to how strategies fit the program’s risk and governance standards.
The program is described as a long-term capital cooperation framework with rolling admissions and phased deployment. Bitget said it plans to disclose developments over time, including participation figures, deployed capital, and strategy distribution.
Bitget also indicated that it will release additional materials over time, such as product specifications, market structure research, and institutional case studies related to how participating firms use capital and trading infrastructure.
Bigger picture: capital, infrastructure, and execution
Beyond funding, Bitget positioned Project Archimedes as part of its broader role as a capital partner that combines market insight with trading infrastructure and access to an international institutional network. The company said the structure is intended to help emerging teams build a stronger foundation while allowing mature institutions to scale proven strategies.
For investors watching the institutional quant landscape, the key takeaway is the emphasis on capital efficiency and risk control—areas that can determine whether strategies can grow as market competition and financing frictions tighten. The next test will be how quickly Bitget advances participation and deployment, and whether the governance and unified-account mechanics translate into improved scalability for the targeted market-neutral strategies.
Looking ahead, Bitget said program updates will be disclosed over time, including participation, deployed capital, and strategy distribution. Institutions evaluating the program may also watch for the release of product specifications and case studies that detail how firms operationalize collateral and execution under Bitget’s unified framework.
